INOFEA is a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that specialises in providing tailor-made enzyme solutions for the production processes of high-value compounds including Biologics such as mRNA and Bioconjugates, as well as small molecule Active Pharmaceutical Ingredients (APIs). Established in 2014, INOFEA leverages its unique and patented enzyme immobilisation and shielding technology to enhance enzyme stability while maintaining high activity levels. This innovative approach ensures there is no loss of enzyme during the production process, facilitating the creation of purer vaccines and therapeutics, which translates into significant cost savings and expedited time-to-market.

Services include:
- Active Pharmaceutical Ingredients (APIs)
- Biologics
- Enzyme Solutions
- Nanomaterial Design and Production
- Business Development in High-Value Industrial Applications

INOFEA is committed to advancing the pharmaceutical industry with its innovative solutions and technologies. To learn more about their offerings and capabilities, please visit inofea.com.